Kelyon consolidates its role of international excellence in the field of Digital Health
The AboutPharma Digital Awards, now in their 11th edition, brought together more than 560 Digital Healthcare projects divided into 16 categories. After winning in 2022 with AZFastnet – an online platform developed for AstraZeneca that simplifies and speeds up tests to determine the mutational status of specific genes in oncology and oncohaematology – came the encore for the Campania-based company led by Gaetano Cafiero.
This time the Neonatal Screening Campania (SNC), developed by Kelyon in collaboration with DXC Technology for Soresa Spa within the framework of the Campania Region’s Sinfonia project, was awarded the prize on 16 May in Milan in the ‘HTA, supply and care’ section. Beaten in the finals were proposals from Pfizer Italia, Angelini Pharma, Advanced Accelerator Applications, Horizon and Hollister Incorporated. The Neonatal Screening Campania (SNC) platform enables multi-centre and multi-disciplinary cooperation for the management of information flows in order to promptly detect hereditary metabolic diseases and some rare diseases – thanks to the know-how of CEINGE Advanced Biotechnologies – and hearing disorders, as envisaged by the Essential Levels of Assistance (LEA), while at the same time allowing the registration of certificates of assistance in childbirth (CeDAP).
Kelyon’s CEO, Gaetano Cafiero, is satisfied:
Winning this prestigious award again is further recognition of Kelyon’s commitment to creating solutions that have a positive daily impact in the prevention of diseases, particularly rare ones, through the fundamental use of screening. The competence and passion that drive our team are confirmed. We thank the many hospitals and pharmaceutical companies that have been relying on our solutions for years.
Since its foundation in 2008, Kelyon’s mission has been to design, develop, and promote digital solutions that improve the patient experience in the management of life-changing diseases. In this context of constant research and innovation, the platform for neonatal screening is one of the most advanced preventive medicine tools to avoid irreversible damage to newborns and stands to become a model for all other regional administrations.
